An Illumina office building is shown in San Diego on Oct. 20, 2023. REUTERS/Mike Blake San Diego-based genetics technology company Illumina on Tuesday accused EU antitrust regulators of over-extending their powers in their scrutiny of its $7.1 billion for GRAIL while regulators accused the U.S. life sciences company of seeking to rewrite the EU merger rule book. The case underlines the European Commission‘s determination to apply a rarely used power called Article 22 to examine deals by large companies that may aim to shut down smaller rivals, even if the deals are below the EU merger revenue threshold. The tougher EU regulatory approach however has triggered concerns among compani
Hence then, the article about illumina accuses eu of over extending its powers in assessing grail deal was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Illumina Accuses EU of Over-Extending its Powers in Assessing Grail Deal )